DYN
DYN
NASDAQ · Biotechnology

Dyne Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$17.54
-1.30 (-6.90%)
As of May 9, 1:26 AM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 17 85%
Hold 3 15%
Sell 0 0%
Price Target
Analyst Price Target +457.9% upside
Low Target $76.65
Average Target $97.86
High Target $132.93
Current Price $17.54
Current
$17.54
Target
$97.86
$76.65 $97.86 avg $132.93
Scenario Analysis
Bear Case
$76.65
337.0%
Low target
Base Case
$97.86
+457.9%
Avg target
Bull Case
$132.93
+657.9%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$25.00
-29.8% from high
52-Week Low
$8.06
+117.6% from low
50-Day SMA
$18.16
-3.4% vs SMA
200-Day SMA
$14.91
+17.6% vs SMA
RSI (14)
28.7
Oversold
Target vs 52W High
$97.86
+291.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%